AstraZeneca (AZN) Market Cap 1993–2026

As of January 27, 2026, AstraZeneca had a market cap of $296.36 billion, which increased by 1.44% compared to the previous trading day. Market capitalization, often referred to as market cap, represents the total value of a company's outstanding shares on the stock market and is a common measure of its overall size and valuation.

Data updated: Jan 27, 2026, 4:00 PM ET
AstraZeneca logo

AstraZeneca PLC (AZN)

🌍 United Kingdom 📈 NASDAQ 🏭 Health Care 🏢 Pharmaceuticals
Latest Market Cap
$296.36B ▲ 1.44%
Jan 1, 2026
$285.03B ▲ 3.98%
1 Year Ago
$215.74B ▲ 37.37%
All-Time High
$298.7B ▼ 0.78%


Loading data...


Note: Each point on the chart represents the market capitalization at the end of the trading day.
Source: Data compiled from EDGAR filings, Bloomberg and Yahoo Finance.


📈 AstraZeneca Market Cap History by Year and Month

AstraZeneca Market Cap History by Year and Month
Year / MonthMarket Cap% Change
2026$296.36B▲ 3.98%
$296.36B▲ 3.98%
2025$285.03B▲ 40.33%
2024$203.112B▼ 2.72%
2023$208.785B▼ 0.63%
2022$210.112B▲ 16.39%

All market cap values reflect closing prices for the period shown.


📊 AstraZeneca Market Cap and Other Industry Peers

Below are selected companies from the Health Care sector / subsector:

  1. $929.07B
  2. $540.72B
  3. $395.78B
  4. $296.36B
  5. $267.91B
  6. $256.13B
  7. $234.39B
  8. $189.22B
  9. $188.18B
  10. $186.12B
  11. $174.91B
  12. $166.51B
  13. $150.56B
  14. $138.75B
  15. $135.59B
  16. $113.12B
  17. $55.06B
  18. $17.4B
  19. $15.12B
  20. $12.23B


Data reflect the most recent market capitalization values available.

💡 What Is Market Capitalization and How Do We Calculate It?

For AstraZeneca PLC (AZN), market capitalization represents the total market value of the company’s publicly traded shares. It helps investors understand AstraZeneca’s size within the health care sector and compare it with other companies in the same industry.

In most cases, market capitalization is calculated by multiplying the current share price by the number of basic shares outstanding. Basic shares represent the actual number of common shares that currently exist, without including potential future shares from employee stock options, RSUs, warrants, or convertible securities. For example, if AstraZeneca had one million basic shares and each traded at $50, its market capitalization would be $50 million.

Formula:
Market Cap = Share Price × Shares Outstanding

The value of AstraZeneca’s market capitalization changes throughout the trading day because it mainly depends on the current share price. The number of shares outstanding typically remains stable unless the company issues new shares, buys back its own stock, or grants stock options to employees.

Based on the latest data, AstraZeneca had a market capitalization of $296.36 billion, placing it in the mega-cap category within the health care industry.

Disclaimer: Despite all efforts, there may still be minor inaccuracies present in the data.